Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


AMSilk Starts Worldwide Distribution of Spidersilk as Cosmetic Ingredient


Planegg, Germany, November 20, 2013 - AMSilk has developed the world’s first industrial manufacturing process for Spidersilk, a protein which is similar to natural spider silk. The biocompatible material is used as building block for super strong fibers, innovative medical devices, and dermatology products. Moreover, it is now for the first time available as cosmetic ingredient. Spidersilk is the first functional silk on the market tested and approved for cosmetic formulations.

„Most products advertising with the word ‚silk’ only contain hydrolyzed protein which has been cut into pieces and thus lost almost all of the function and benefits of natural silk,“ says Dr. Ute Slotta, who has developed the Spidersilk formulations. „With our product we can now offer a truly functional silk formulation to cosmetic companies.”

Spidersilk adds smoothness and moisture management to the skin, leaving a silky feeling. Formulations using Spidersilk microbeads make the skin appear softer.

“We are excited to have our production now at a point where we can supply the cosmetic industry with unique and functional new ingredients,” says Dr. Lin Roemer, co-founder and Head of Research and Development at AMSilk.

Besides supplying raw materials to cosmetic manufacturers, AMSilk is also testing a concept study within the European Union for special cosmetic products under www.spidersilk.info.

Spidersilk is available as a powder, microbeads, and hydrogel. For sampling and product prices contact sales@amsilk.com.

For technical details go to:
http://www.amsilk.com/fileadmin/content/TechInsight_Cosmetics.pdf


About AMSilk
Spider silk has attracted man's interest for thousands of years, mainly due to its toughness and elasticity. The silk is biocompatible and can be used in formulations for specialized coatings, films, nonwovens and in pharmaceuticals. Spider silk has evolved over millions of years resulting in a combination of properties that far exceed any man-made material. AMSilk has developed a proprietary process for producing spider silk on an industrial scale. In March 2013 AMSilk had already announced that the company has produced the world’s first competitive man-made spider silk fiber, called Biosteel®, which is made entirely from recombinant silk proteins.

AMSilk was founded in 2008 and is located at the IZB in Planegg near Munich. AMSilk's investors are MIG Funds and AT Newtec, Munich. Projects are partially funded through grants from the German Federal Ministry of Education and Research and the Bavarian Ministry of Economic Affairs, Infrastructure, Transport and Technology with project management provided by the PTJ and VDI.

AMSilk and Biosteel are registered trademarks of AMSilk GmbH, Germany


Contact

AMSilk GmbH
Axel H. Leimer
Managing Director
Am Klopferspitz 19 im IZB

82152 Planegg
Germany
Phone: +49 (0)89 38156-4430
Email: pr@amsilk.com


Publisher Contact Information:

AMSilk
+49 (0)89 38156-4430
pr@amsilk.com

Company profile of AMSilk
Past press releases of AMSilk.

Data


27,452
Tech investments
From our Online Data Service
17,708
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Oct 16€11.0MOther Biotechnology & Healthcare
Oct 16€6.3MBiotechnology
Oct 15€4.0MSecurity
Oct 15€25.0MBiotechnology
Oct 15€169.0MOther Communications
Oct 15€4.1MSmart cards

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.